Citation: Wagner, The use of gadolinium chelates for x-ray digital subtraction angiography (vol 36, pg 257, 2001), INV RADIOL, 36(9), 2001, pp. 553-553
Citation: Gee,langer,ross,rao,wagner,domnin,camus,pooley,price,browne,carbone,bragg,gibbs,magnani,wilson,dunnigan,johnson,fedotov,band, Exposure to amphibole-asbestos and mixed fibers: Discussion, CAN MINERAL, 2001, pp. 63-70
Citation: Bragg,ross,gibbs,williams-jones,nolan,magnani,rickards,pooley,langer,gee,rao,dunnigan,camus,browne,wagner, Exposure to commercial chrysotile - Mineralogy, modern products and exposures: Discussion, CAN MINERAL, 2001, pp. 121-125
Citation: Wilson,camus,ross,browne,magnani,langer,domnin,gibbs,dunnigan,churg,wagner,rao,higahsi, Exposure to commercial chrysotile - Historical perspectives of the health effects: Discussion, CAN MINERAL, 2001, pp. 239-241
Authors:
Murray, R
Browne, K",Langer,Bragg,Rao,Nolan,Gibbs,Dunnigan,Richards,Camus,Wilson,Wagner,Magnani,Pooley,Gee,Price,Hoskins
Citation: R. Murray et Browne, K",langer,bragg,rao,nolan,gibbs,dunnigan,richards,camus,wilson,wagner,magnani,pooley,gee,price,hoskins, General discussion of five topics, CAN MINERAL, 2001, pp. 283-289
Citation: Wagner, Incremental costs of enrolling cancer patients in clinical trials: A population-based study (vol 91, pg 847, 1999), J NAT CANC, 92(2), 2000, pp. 164-165
Citation: Altorki, Nk",wagner,"kaiser, Lr",altorki, New telemetric system for daily pulmonary function surveillance of lung transplant recipients - Discussion, ANN THORAC, 68(6), 1999, pp. 2038-2038
Citation: Fuster,edelman,toussaint,amarenco,wagner,brezinski,insull,shankar, Panel discussion III - Overview of imaging: Characterization of the vulnerable plaque with emphasis on other atherosclerotic regions and imaging modalities, AM HEART MG, 1999, pp. 259-265
Citation: Fuster,wagner,libby,ku,insull,lee,cornhill,badimon,ganz, Panel discussion V - Mechanical forces in plaque disruption, AM HEART MG, 1999, pp. 359-363